
Current Issues in Molecular Biology, Journal Year: 2025, Volume and Issue: 47(5), P. 333 - 333
Published: May 6, 2025
Hospital-acquired infections (HAIs) previously focused mainly on multidrug-resistant (MDR) bacteria, with less attention viruses. The COVID-19 pandemic highlighted the importance of controlling viral infections. Human rhinoviruses (HRVs) are among viruses responsible for HAIs. HRVs non-enveloped that infect upper airways after airborne or direct transmission. Due to their lack a membrane envelope, exhibit moderate resistance commonly applied alcoholic disinfectants. Therefore, there is significant need develop alternative disinfection and hand sanitation strategies control HRV in healthcare settings without posing risk human health. antimicrobial activity safety rhamnolipids nano-micelles (RMN) against MDR-bacteria several viruses, including SARS-CoV-2, were confirmed recently. Also, we demonstrated superior RMN over rhamnolipids. In current study, molecular docking weak interactions HRV-1A (minor group) compared HRV-14 (major group), suggesting antiviral towards major group rhinoviruses. To biologically validate these data, was prepared characterized, then HRV-16 HRV-1B infection HeLa cells assessed. showed complete inhibition recovery 100% cell viability. contrast, only partial approximately 50% protection observed. might be recommended as disinfectant and/or sanitizer component spread RVs hospital care elsewhere reduce incidence respiratory
Language: Английский